Kenneth Kovan

Kenneth Kovan

Founder at BIOVAXYS TECHNOLOGY CORP.

Net worth: 514 700 $ as of 2024-02-28

Health Technology
Consumer Services
Commercial Services

Profile

Kenneth E.
Kovan
founded BioVaxys Technology Corp., AVAX Technologies, Inc. and BioVaxys LLC.
Currently, he occupies the position of President of Chaperone Technologies, Inc. and President & Chief Operating Officer for BioVaxys Technology Corp., President & Chief Operating Officer for BioVaxys LLC (a subsidiary of BioVaxys Technology Corp.).
He is also Managing Principal & Owner at Bingham Hill Ventures.
Mr. Kovan previously was Principal at GSK Plc, Principal at Wyeth-Ayerst Research, Partner at Horizon Discovery Ltd.
and Principal at Thomas Jefferson University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-25 7,352,862 ( 5.07% ) 514 700 $ 2024-02-28

Kenneth Kovan active positions

CompaniesPositionStart
BIOVAXYS TECHNOLOGY CORP. Founder -
President -
Founder -
Bingham Hill Ventures Corporate Officer/Principal -
All active positions of Kenneth Kovan

Former positions of Kenneth Kovan

CompaniesPositionEnd
Corporate Officer/Principal -
Wyeth-Ayerst Research Corporate Officer/Principal -
GSK PLC Corporate Officer/Principal -
Thomas Jefferson University Corporate Officer/Principal -
AVAX TECHNOLOGIES, INC. Founder -
See the detail of Kenneth Kovan's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth Kovan's experience

Connections

10

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
AVAX TECHNOLOGIES, INC.

Health Technology

GSK PLC

Health Technology

Private companies6
Wyeth-Ayerst Research

Health Technology

BioVaxys Technology Corp.

Health Technology

Bingham Hill Ventures

Commercial Services

See company connections
  1. Stock
  2. Insiders
  3. Kenneth Kovan